Serum Cytokine Levels in Infectious Mononucleosis at Diagnosis and Convalescence

References

• Masucci M.G., Ernberg I. Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol 1994; 2: 125–130
   PubMedGoogle Scholar
• Lai P.K., Mackay-Scollay E.M., Alpers M.P. Epidemiological studies of Epstein-Barr herpesvirus infection in Western Australia. J Hyg Land 1975; 74: 329–337
   PubMedGoogle Scholar
• Hesse J., Ibsen K.K., Krabbe S., Uldall P. Prevalence of antibodies to Epstein-Barr virus (EBV) in childhood and adolescence in Denmark. Scand J Infect Dis 1983; 15: 335–338
   PubMed Web of Science ®Google Scholar
• Straus S.E. Acute progressive Epstein-Barr virus infections. Ann Rev Med 1992; 43: 437–449
   PubMed Web of Science ®Google Scholar
• Niedobitek G., Young L.S. Epstein-Barr virus persistence and virus associated tumors. Lancet 1994; 343: 333–335
   PubMed Web of Science ®Google Scholar
• Vandenabeele P., Jayaram B., Devos R., Shaw A., Fiers W. Interleukin-1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein Barr virus transformed human B-cell line. Eur J Immunol 1988; 18: 1027–1031
   PubMed Web of Science ®Google Scholar
• Reisbach G., Sindermann J., Kremer J.P., Hultner L., Wolf H., Dormer P. Macrophage colony-stimulating factor (CSF-1) is expressed by spontaneously outgrown EBV-B cell lines and activated normal B lymphocytes. Blood 1989; 74: 959–964
   PubMed Web of Science ®Google Scholar
• Scala G., Kuang Y.D., Hall R.E., Muchmore A.V., Oppenheim J.J. Accessory cell function of human B cells. I. Production of both interleukin-1-like activity and an interleukin-1 inhibitory factor by an EBV transformed human B-cell line. J Exp Med 1984; 159: 1637–1652
   PubMed Web of Science ®Google Scholar
• Tostao G., Tanner J., Jones K.D., Revel M., Pike S.E. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus immortalized B cells. J Virol 1990; 64: 3033–3041
   PubMed Web of Science ®Google Scholar
• Yokoi T., Miyawaki T., Yachie A., Kato K., Kasahara Y., Taniguchi N. Epstein-Barr virus immortalized B cells produce IL-6 as an autocrine growth factor. Immunology 1990; 70: 100–105
   PubMed Web of Science ®Google Scholar
• Yamanaka H.I., Karpas A. Identity of human B-cell line cytotoxic lymphokine with tumor necrosis factor type beta. Proc Natl Acad Sci USA 1989; 86: 1343–1347
   PubMed Web of Science ®Google Scholar
• Jochems G.S., Klein M.R., Jordens R., et al. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines. Hum Antibodyies Hybridomas 1991; 2: 57–64
   PubMedGoogle Scholar
• Estrov Z., Kurzrock R., Pocsik E., et al. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J Exp Med 1993; 111: 163–714
   Google Scholar
• Gibbons D.L., Rowe M., Cope A.P., Feldmann M., Brennan F.M. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B-cells and differentiated Burkitt's lymphoma cell lines. Eur J Immunol 1994; 28: 1879–1885
   Web of Science ®Google Scholar
• Seregina T.M., Mekshenkov R.L., Turetskaya R.L., Nedospasov S.A. An autocrine growth factor constitutively produced by a human lymphoblastoid B-cell line is serologically related to lymphotoxin (TNF-beta). Mol Immunol 1989; 26: 339–420
   PubMed Web of Science ®Google Scholar
• Foss H.-D., Herbst H., Hummel M., et al. Patterns of cytokine gene expression in infectious mononucleosis. Blood 1994; 83: 707–712
   PubMed Web of Science ®Google Scholar
• Linde A., Andersson B., Svenson S.B., et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis 1992; 165: 994–1000
   PubMed Web of Science ®Google Scholar
• Tosato G., Tanner J., Jones K.D., Revel M., Pike S.E. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J Virol 1990; 64: 3033–3410
   PubMed Web of Science ®Google Scholar
• Estrov Z., Kurzrock R., Wetzler M., et al. Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. Blood 1991; 78: 1476–1484
   PubMed Web of Science ®Google Scholar
• Jandl J.H. Blood Textbook of Hematology. Little, Brown and Company, New York 1996; 718–724
   Google Scholar
• Andersson J., Andersson U. Characterization of cytokine production in infectious mononucleosis studied at a single-cell level in tonsil and peripheral blood. Clin Exp Immunol 1993; 92: 7–13
   PubMed Web of Science ®Google Scholar
• Andersson J., Abrams J., Bjork L., et al. Concomitant in vivo production of 19 different cytokines in human tonsils. Immunol 1994; 83: 16–24
   PubMed Web of Science ®Google Scholar
• Hornef M.W., Wagner H.J., Kruse A., Kirchner H. Cytokine production in whole blood assay after Epstein-Barr virus infection in vivo. Clin Diagn Lab Immunol 1995; 2: 209–213
   PubMedGoogle Scholar
• Blazar B.A., Sutton L.M., Strome M. Self-stimulating growth factor production by B cell lines derived from Burkitt's lymphoma and other lines transformed in vitro by Epstein-Barr virus. Cancer Res 1983; 43: 4562–4568
   PubMed Web of Science ®Google Scholar
• Gordon J., Ley S.C, Melamed M.D., Amam P., Hughes-Jones N.C. Soluble factor requirements for the auto-stimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus. J Exp Med 1984; 159: 1554–1559
   PubMed Web of Science ®Google Scholar
• Gordon J., Ley S.C, Melamed M.D., English L.S., Hughes-Jones N.C. Immortalized B lymphocytes produce B cell growth factor. Nature 1984; 310: 145–147
   PubMed Web of Science ®Google Scholar
• Tosato G., Gerrard T.L., Goldman N.G., Pike S.E. Stimulation of EBV-activated human B-cells by monocytes and monocyte products. Role of IFNβ2/B cell stimulatory factor 2/IL-6. J Immunol 1988; 140: 4329–4336
   PubMed Web of Science ®Google Scholar
• Uchibayashi N., Kikutani H., Barsumian E.L., et al. Recombinant soluble Fc εreceptor II (Fcε/CD23) has IgE binding activity but no B-cell growth promoting activity. J Immunol 1989; 142: 3901–3908
   PubMed Web of Science ®Google Scholar
• Rimsky L., Wakasugi H., Ferrara P., et al. Purification to homogeneity and NH2 terminal amino acid sequence of a novel interleukin 1 species derived from a human B-cell line. J Immunol 1986; 136: 3304–3310
   PubMed Web of Science ®Google Scholar
• Wakasugi H., Rimsky L., Mahe Y., et al. Epstein-Barr virus containing B cell line produces interleukin 1 that is used as a growth factor. Proc Natl Acad Sci USA 1987; 84: 804–880
   PubMed Web of Science ®Google Scholar
• Paul C.C, Keller J.R., Armpriester J.M., Bauman M.A. Epstein-Barr transformed B-lymphocytes produce interleukin-5. Blood 1990; 75: 1400–1403
   PubMed Web of Science ®Google Scholar
• Baumann M.A., Paul C.C. Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes. Blood 1992; 79: 1763–1767
   PubMed Web of Science ®Google Scholar
• Pike S.E., Markey S.P., Ijames C., Jones K.D., Tosato G. The role of lactic acid in autocrine B-cell growth stimulation. Proc Natl Acad Sci USA 1991; 88: 11081–5
   PubMed Web of Science ®Google Scholar
• Schuster V., Herold M., Wachter H., Reinegger G. Serum concentrations of interferon gamma, interleukin-6, and neopterin in patients with infectious mononucleosis and other Epstein-Barr virus-related lymphoproliferative diseases. Infection 1993; 21: 210–13
   PubMed Web of Science ®Google Scholar
• Biglino A., Sinicco A., Forno B., et al. Serum cytokine profiles in acute primary HLV-1 infection and infectious mononucleosis. Clin Immunol Immunopathol 1996; 78: 61–9
   PubMedGoogle Scholar
• Taga H., Taga K., Wang F., Chretien J., Tosato G. Human and viral interleukin-10 in acute Epstein-Barr-induced infectious mononucleosis. J Infect Dis 1995; 171: 1347–50
   PubMed Web of Science ®Google Scholar
• Taga K., Chretien J., Cherney B., Diaz L., Brown M., Tostao G. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J Clin Invest 1994; 94: 251–60
   PubMed Web of Science ®Google Scholar
• Estrov Z., Kurzrock R., Talpaz M. Interruption of endogenous growth regulatory networks: a novel approach to inhibition of leukemia cell proliferation. FORUM Trends Exp Clin Med 1993; 3: 306–18
   Google Scholar